Parvodicin C3

Parvodicin C3 is a glycopeptide antibiotic. Parvodicin C3 has inhibitory effect on Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus and Enterococcus faecalis[1].

Product Specifications

CAS Number

[110882-86-5]

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Smiles

OC1=CC=C(C(NC)C(NC(CC2=CC=C(OC3=C(O[C@H]4[C@H](NC(CCCCCCCCC(C)C)=O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O4)C(OC5=CC=C6C=C5Cl)=CC7=C3)C=C2)C(NC8C(NC7C(NC(C9=CC(C%10=C%11C=C(O)C=C%10O[C@@H]%12[C@@H](O)[C@@H](O)[C@H](O)[C@@H](COC(C)=O)O%12)=C(O)C=C9)C(NC(C6O)C(NC%11C(O)=O)=O)=O)=O)=O)=O)=O)C=C1OC%13=CC8=C(Cl)C(O)=C%13

Molecular Formula

C85H90Cl2N8O30

Molecular Weight

1774.57

References & Citations

[1]S B Christensen, et al. Parvodicin, a novel glycopeptide from a new species, Actinomadura parvosata: discovery, taxonomy, activity and structure elucidation. J Antibiot (Tokyo) . 1987 Jul;40 (7) :970-90.